Atlas Trials

Red-Cell Aplasia, Pure

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Red-Cell Aplasia, Pure

RecordFirmDate
Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa (NCT02648126)The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)2015-11-01
Identifying Characteristics of Bone Marrow Failure Syndromes (NCT00315419)Office of Rare Diseases (ORD)2006-04-01
Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia (NCT00229619)National Heart, Lung, and Blood Institute (NHLBI)2005-09-01
Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin (NCT00210951)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2003-05-01
A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins (NCT00211029)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2003-01-01
Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders (NCT00005893)Fairview University Medical Center2000-06-01

Track Red-Cell Aplasia, Pure automatically

Every clearance here is in the API, with alerts when new ones post.